More articles from Continuing Education

  • Open Access
    New Developments in Myeloma Treatment and Response Assessment
    Françoise Kraeber-Bodéré, Bastien Jamet, Davide Bezzi, Elena Zamagni, Philippe Moreau and Cristina Nanni
    Journal of Nuclear Medicine September 1, 2023, 64 (9) 1331-1343; DOI: https://doi.org/10.2967/jnumed.122.264972
  • Open Access
    Theranostics in Hematooncology
    Andreas K. Buck, Sebastian E. Serfling, Sabrina Kraus, Samuel Samnick, Niklas Dreher, Takahiro Higuchi, Leo Rasche, Hermann Einsele and Rudolf A. Werner
    Journal of Nuclear Medicine July 1, 2023, 64 (7) 1009-1016; DOI: https://doi.org/10.2967/jnumed.122.265199
  • 18F-FDG PET/CT in the Management of Osteosarcoma
    Chiwoo Oh, Michael W. Bishop, Steve Y. Cho, Hyung-Jun Im and Barry L. Shulkin
    Journal of Nuclear Medicine June 1, 2023, 64 (6) 842-851; DOI: https://doi.org/10.2967/jnumed.123.265592
  • Amino Acid PET in Neurooncology
    Norbert Galldiks, Philipp Lohmann, Gereon R. Fink and Karl-Josef Langen
    Journal of Nuclear Medicine May 1, 2023, 64 (5) 693-700; DOI: https://doi.org/10.2967/jnumed.122.264859
  • Role of 18F-FDG PET/CT in Large Vessel Vasculitis and Polymyalgia Rheumatica
    Riemer H.J.A. Slart, Pieter H. Nienhuis, Andor W.J.M. Glaudemans, Elisabeth Brouwer, Olivier Gheysens and Kornelis S.M. van der Geest
    Journal of Nuclear Medicine April 1, 2023, 64 (4) 515-521; DOI: https://doi.org/10.2967/jnumed.122.265016
  • From Concept to Regulatory Drug Approval: Lessons for Theranostics
    Marlon Perera and Michael J. Morris
    Journal of Nuclear Medicine December 1, 2022, 63 (12) 1793-1801; DOI: https://doi.org/10.2967/jnumed.121.263301
  • Oligometastatic Prostate Cancer: Current Status and Future Challenges
    Hossein Jadvar, Andre Luis Abreu, Leslie K. Ballas and David I. Quinn
    Journal of Nuclear Medicine November 1, 2022, 63 (11) 1628-1635; DOI: https://doi.org/10.2967/jnumed.121.263124
  • Dosimetry in Radiopharmaceutical Therapy
    Joe O’Donoghue, Pat Zanzonico, John Humm and Adam Kesner
    Journal of Nuclear Medicine October 1, 2022, 63 (10) 1467-1474; DOI: https://doi.org/10.2967/jnumed.121.262305
  • Pretargeting: A Path Forward for Radioimmunotherapy
    Sarah M. Cheal, Sebastian K. Chung, Brett A. Vaughn, Nai-Kong V. Cheung and Steven M. Larson
    Journal of Nuclear Medicine September 1, 2022, 63 (9) 1302-1315; DOI: https://doi.org/10.2967/jnumed.121.262186
  • Advances in Detector Instrumentation for PET
    Andrea Gonzalez-Montoro, Muhammad Nasir Ullah and Craig S. Levin
    Journal of Nuclear Medicine August 1, 2022, 63 (8) 1138-1144; DOI: https://doi.org/10.2967/jnumed.121.262509

Pages